The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Durvalumab outcomes for patients with PD-L1 positive and negative stage III unresectable non-small cell lung cancer treated at Veterans Health Administration facilities.
 
Elizabeth M. Burton
No Relationships to Disclose
 
Amanda Moore
No Relationships to Disclose
 
Zohra Nooruddin
Employment - Thermo Fisher Scientific (I)
Consulting or Advisory Role - Gilead Sciences
Research Funding - AstraZeneca
 
Ion Cotarla
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Consulting or Advisory Role - Gerson Lehrman Group; ISR reports; M3
 
Daniel Simmons
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Laura Davis
No Relationships to Disclose
 
Kelly R Reveles
Employment - Bristol-Myers Squibb (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb (I)
Consulting or Advisory Role - Ferring
Speakers' Bureau - Ferring
Research Funding - Ferring; Merck
 
Paromita Datta
No Relationships to Disclose
 
Gabriel Roman Souza
No Relationships to Disclose
 
Omoruyi Credit Irabor
Employment - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca
 
Kathleen Franklin
No Relationships to Disclose
 
Xavier Jones
Research Funding - AstraZeneca/MedImmune (Inst)
 
Christopher R Frei
Research Funding - AstraZeneca